Zemkova Hana, Khadra Anmar, Rokic Milos B, Tvrdonova Vendula, Sherman Arthur, Stojilkovic Stanko S
Department of Cellular and Molecular Neuroendocrinology, Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic.
Pflugers Arch. 2015 Apr;467(4):713-26. doi: 10.1007/s00424-014-1546-7. Epub 2014 Jun 11.
Allosteric modulators of ligand-gated receptor channels induce conformational changes of the entire protein that alter potencies and efficacies for orthosteric ligands, expressed as the half maximal effective concentration (EC50) and maximum current amplitude, respectively. Here, we studied the influence of allostery on channel pore dilation, an issue not previously addressed. Experiments were done using the rat P2X4 receptor expressed in human embryonic kidney 293T cells and gated by adenosine 5'-triphosphate (ATP) in the presence and absence of ivermectin (IVM), an established positive allosteric regulator of this channel. In the absence of IVM, this channel activates and deactivates rapidly, does not show transition from open to dilated states, desensitizes completely with a moderate rate, and recovers only fractionally during washout. IVM treatment increases the efficacy of ATP to activate the channel and slows receptor desensitization during sustained ATP application and receptor deactivation after ATP washout. The rescue of the receptor from desensitization temporally coincides with pore dilation, and the dilated channel can be reactivated after washout of ATP. Experiments with vestibular and transmembrane domain receptor mutants further established that IVM has distinct effects on opening and dilation of the channel pore, the first accounting for increased peak current amplitude and the latter correlating with changes in the EC50 and kinetics of receptor deactivation. The corresponding kinetic (Markov state) model indicates that the IVM-dependent transition from open to dilated state is coupled to receptor sensitization, which rescues the receptor from desensitization and subsequent internalization. Allosterically induced sensitization of P2X4R thus provides sustained signaling during prolonged and repetitive ATP stimulation.
配体门控受体通道的变构调节剂可诱导整个蛋白质的构象变化,从而改变对正构配体的效力和效能,分别表示为半数最大有效浓度(EC50)和最大电流幅度。在此,我们研究了变构对通道孔扩张的影响,这是一个此前未被探讨过的问题。实验使用在人胚肾293T细胞中表达的大鼠P2X4受体进行,该受体由5'-三磷酸腺苷(ATP)门控,实验中存在和不存在伊维菌素(IVM),IVM是该通道已确定的正变构调节剂。在不存在IVM的情况下,该通道快速激活和失活,不显示从开放状态到扩张状态的转变,以中等速率完全脱敏,并且在洗脱过程中仅部分恢复。IVM处理可提高ATP激活通道的效能,并在持续施加ATP期间减缓受体脱敏以及在ATP洗脱后减缓受体失活。受体从脱敏状态的恢复在时间上与孔扩张一致,并且在ATP洗脱后扩张的通道可以重新激活。对前庭和跨膜结构域受体突变体的实验进一步证实,IVM对通道孔的开放和扩张有不同影响,前者导致峰值电流幅度增加,后者与EC50的变化以及受体失活动力学相关。相应的动力学(马尔可夫状态)模型表明,IVM依赖的从开放状态到扩张状态的转变与受体敏化相关联,这使受体免于脱敏和随后的内化。因此,变构诱导的P2X4R敏化在长时间和重复的ATP刺激期间提供持续信号传导。